GMA News
Zubiri, kinontra si Roque sa pahayag na 'di dapat pihikan ang mga Pinoy sa COVID-19 vaccine
Senate Majority Leader Miguel Zubiri stated that it is unfair to prevent Filipinos from choosing their preferred COVID-19 vaccine brand.
Zubiri's statement was a response to Presidential Spokesperson Harry Roque Jr.'s remark that Filipinos cannot be picky about vaccine brands due to the large number of people who need to be inoculated.
Roque made his comments following the announcement of Health Secretary Francisco Duque III about the Philippines securing 25 million doses of the Sinovac vaccine from China, which had not yet received emergency use authorization in the US and Europe.
Zubiri argued that people should be given a choice, highlighting the AstraZeneca vaccine as an example.
He noted that the AstraZeneca vaccine costs P500 for two doses, has shown over 90% effectiveness in trials, and has already obtained emergency use authorization from regulatory bodies in the US and UK, among other countries.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
Malacañang has affirmed the safety and effectiveness of the Sinovac COVID-19 vaccine, with China's Sinovac Biotech expected to provide 25 million doses to the Philippines this year.
Read more →
Comedian Vice Ganda questioned the government's stance on not allowing Filipinos to be picky about the COVID-19 vaccines they receive.
Read more →
Vice President Leni Robredo asserted that Filipinos have the right to choose which COVID-19 vaccine they prefer, emphasizing that health is a right, not a privilege.
Read more →
British pharmaceutical firm AstraZeneca has applied for emergency use authorization (EUA) for its COVID-19 vaccine in the Philippines, marking the second such application after Pfizer.
+1
Read more →
The Philippine Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to the Pfizer-BioNTech COVID-19 vaccine, making it the first to receive such approval in the country.
+2
Read more →